60 results
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
Matters
From time to time, the Company is involved in various disputes and litigation matters that arise in the ordinary course of business. To date … disputes and litigation matters that arise in the ordinary course of business. To date, we have had no material pending legal proceedings, and we
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
to time, the Company is involved in various disputes and litigation matters that arise in the ordinary course of business. To date, the Company has … to materially affect, our financial reporting.
PART II
ITEM 1. LEGAL PROCEEDINGS.
From time to time, we are involved in various disputes and litigation
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
issued to us or to any future licensors may be challenged and subsequently narrowed, invalidated, or circumvented. Patent litigation is widespread … in the biotechnology industry and could harm our business. Litigation might be necessary to protect our patent position or to determine the scope
POS AM
c27zlalyocqbl2r
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
8-K
EX-10.1
m32h49n0kzj5n6xsoynx
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
424B5
0xklb
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
di3diroux9coe7pptdlr
7 Mar 24
Prospectus supplement for primary offering
9:57pm
8-K
frlls7iv
5 Dec 23
Departure of Directors or Certain Officers
8:45am
8-K
e0dum
30 Nov 23
Regulation FD Disclosure
9:20am
424B5
g72cwvjf8436zlc
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
i1bd5wsvmt91aywdfcu
16 Nov 23
Shelf registration
5:23pm
S-3
EX-4.3
za6a1rmdf56l0
16 Nov 23
Shelf registration
5:23pm
8-K
EX-99.1
8ny08tg
15 Nov 23
Results of Operations and Financial Condition
5:07pm